α2β1 Integrin Ligand Peptide TFA

• CAT Number: I046025
• Molecular Formula: C16H23F3N4O11
• Molecular Weight: 504.37
• Purity: ≥95%
• Synonyms: (4S)-4-[[2-[[(2S)-2-amino-3-carboxypropanoyl]amino]acetyl]amino]-5-[[(1S)-1-carboxyethyl]amino]-5-oxopentanoic acid;2,2,2-trifluoroacetic acid
• InChI: InChI=1S/C14H22N4O9.C2HF3O2/c1-6(14(26)27)17-13(25)8(2-3-10(20)21)18-9(19)5-16-12(24)7(15)4-11(22)23;3-2(4,5)1(6)7/h6-8H,2-5,15H2,1H3,(H,16,24)(H,17,25)(H,18,19)(H,20,21)(H,22,23)(H,26,27);(H,6,7)/t6-,7-,8-;/m0./s1
• InChIKey: UIPQURHVPOBFKI-WQYNNSOESA-N
• SMILES: CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC(=O)O)N.C(=O)(C(F)(F)F)O

α2β1 Integrin Ligand Peptide TFA(CAT: I046025) is a synthetic peptide that selectively binds to the α2β1 integrin receptor, a collagen receptor involved in cell adhesion, migration, angiogenesis, and tumor progression. By targeting α2β1 integrins, this peptide serves as a valuable tool for studying integrin-mediated signaling pathways in cancer biology, platelet aggregation, and vascular research. It can be used to probe integrin–ligand interactions, modulate extracellular matrix adhesion, and investigate therapeutic strategies in oncology and thrombosis. Supplied as the trifluoroacetate (TFA) salt, the peptide is well-suited for biochemical assays, cell culture experiments, and integrin-targeted drug discovery research.